Gene · 722
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Halting targeted and collateral damage to red blood cells by the complement system. | Semin Immunopathol | 2021 | 34191092 | PubTator, text mining | PubMed |
| Immunoexpression of C4 Binding Protein in Oral Leukoplakia and Oral Squamous Cell Carcinoma. | Iran J Immunol | 2021 | 34190690 | PubTator, text mining | PubMed |
| Research progress on Toll-like receptor signal transduction and its roles in antimicrobial immune responses. | Appl Microbiol Biotechnol | 2021 | 34180006 | PubTator, text mining | PubMed |
| Identification of Dysregulated Complement Activation Pathways Driven by N-Glycosylation Alterations in T2D Patients. | Front Chem | 2021 | 34178943 | PubTator, text mining | PubMed |
| Effect of upstream priming on transient downstream platelet-substrate interactions. | Colloids Surf B Biointerfaces | 2021 | 34175742 | PubTator, text mining | PubMed |
| C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer. | J Exp Clin Cancer Res | 2021 | 34167573 | PubTator, text mining | PubMed |
| Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligands. | Chem Sci | 2021 | 34163823 | PubTator, text mining | PubMed |
| Complement in metabolic disease: metaflammation and a two-edged sword. | Semin Immunopathol | 2021 | 34159399 | PubTator, text mining | PubMed |
| Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms. | Neuron | 2021 | 34157306 | PubTator, text mining | PubMed |
| Serum amyloid P component is an essential element of resistance against Aspergillus fumigatus. | Nat Commun | 2021 | 34145258 | PubTator, text mining | PubMed |
| Cheetah-MS: a web server to model protein complexes using tandem cross-linking mass spectrometry data. | Bioinformatics | 2021 | 34128979 | PubTator, text mining | PubMed |
| Comprehensive Proteomic Profiling of Aqueous Humor Proteins in Proliferative Diabetic Retinopathy. | Transl Vis Sci Technol | 2021 | 34111250 | PubTator, text mining | PubMed |
| Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles. | Adv Sci (Weinh) | 2021 | 34105297 | PubTator, text mining | PubMed |
| Identification of Differentially Expressed circRNAs, miRNAs, and Genes in Patients Associated with Cartilaginous Endplate Degeneration. | Biomed Res Int | 2021 | 34104646 | PubTator, text mining | PubMed |
| Association between NF-kB polymorphism and age-related macular degeneration in a high-altitude population. | PLoS One | 2021 | 34101738 | PubTator, text mining | PubMed |
| SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. | Nat Commun | 2021 | 34099652 | PubTator, text mining | PubMed |
| Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions. | Drugs | 2021 | 34097283 | PubTator, text mining | PubMed |
| A Comparative Study of Microneedling Alone Versus Along with Platelet-Rich Plasma in Acne Scars. | J Cutan Aesthet Surg | 2021 | 34084010 | PubTator, text mining | PubMed |
Fractional Carbon Dioxide Laser versus Fractional Carbon Dioxide Laser with Autologous Intralesional Platelet-rich Plasma in the Treatment of Stable, Non-segmental Vitiligo: A Randomized Comparative Study. | J Cutan Aesthet Surg | 2021 | 34084009 | PubTator, text mining | PubMed |
| Glucosylceramide and galactosylceramide, small glycosphingolipids with significant impact on health and disease. | Glycobiology | 2021 | 34080016 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/722/papers?page=45